The fact that APN production is reduced in conditions such as Type-2 diabetes, metabolic syndrome and cardiovascular disease [28], and that APN prevents atherosclerosis, fatty liver disease and hepatic fibrosis [29-31], makes it an anti-inflammatory molecule. Here, ANPEP is linked to cardiovascular disorder.